Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202421885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Miroslav Kosar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Cannabidiol, Fluorescent Dyes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: MRF_, Roche, Scholarship Fund of the Swiss Chemical Industry.
Abstract (Originalsprache)
Allosteric modulation of cannabinoid receptor type 1 (CB 1 R) offers a promising alternative to conventional therapeutic approaches using orthosteric ligands (OLs). Currently, CB 1 R allosteric modulators (AMs) are characterized based on their ability to modulate binding or functional response of OLs, preventing isolation of individual contributions by allosteric and orthosteric ligands. Herein, we develop the first allosteric fluoroprobe and attendant FRET‐based assay allowing for the direct profiling of CB 1 R AMs without coincubation with an OL. Our allosteric tracer enables differentiation of allosteric and orthosteric ligands as well as their pharmacological profiling at CB 1 R. The utility of this work is highlighted by addressing ambiguities surrounding the binding of cannabidiol (CBD). CBD was found to interact with both allosteric and orthosteric sites of CB 1 R with comparable affinity (p K i =5.34 and 5.67, respectively).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorium für Organische Chemie, ETH Zürich, Vladimir-Prelog-Weg 3, 8093, Zürich, Switzerland.
- Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham NG7 2UH, UK.
- Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.
- Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, 80078, Pozzuoli, Italy.
- Roche Pharma Research & Early Development Roche Innovation Center Basel, Therapeutic Modalities, F. Hoffmann-La Roche Ltd., 4070, Basel, Switzerland.
ORCID-Profile: Miroslav Kosar, Themiya Perera, Rudolf L Z Ganzoni, Roman C Sarott, Leire Borrega-Roman, Rosa Maria Vitale, Alessia Ligresti, Arne C Rufer, Wolfgang Guba, Uwe Grether, Erick M Carreira, Dmitry B Veprintsev, David A Sykes
Förderung
- MRF_
- Roche
- Scholarship Fund of the Swiss Chemical Industry
- Eidgenössische Technische Hochschule Zürich
- Medical Research Council
- Medical Research Foundation
Zitieren
APA
Kosar, M., Perera, T., Ganzoni, R. L. Z., Sarott, R. C., Borrega-Roman, L., Vitale, R. M., Ligresti, A., Rufer, A. C., Guba, W., Grether, U., Carreira, E. M., Veprintsev, D. B., & Sykes, D. A. (2025). Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202421885
Vancouver
Kosar M, Perera T, Ganzoni RLZ, Sarott RC, Borrega-Roman L, Vitale RM, et al. Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202421885
BibTeX
@article{Kosar2025,
author = {Kosar, Miroslav and Perera, Themiya and Ganzoni, Rudolf L Z and Sarott, Roman C and Borrega-Roman, Leire and Vitale, Rosa Maria and Ligresti, Alessia and Rufer, Arne C and Guba, Wolfgang and Grether, Uwe and Carreira, Erick M and Veprintsev, Dmitry B and Sykes, David A},
title = {Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202421885}
}
EUVIMED